These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
296 related articles for article (PubMed ID: 31369420)
1. Prevention and treatment of recurrent Clostridioides difficile infection. Shin JH; Warren CA Curr Opin Infect Dis; 2019 Oct; 32(5):482-489. PubMed ID: 31369420 [TBL] [Abstract][Full Text] [Related]
2. Current and future trends in clostridioides (clostridium) difficile infection management. Khanna S; Gerding DN Anaerobe; 2019 Aug; 58():95-102. PubMed ID: 31054313 [TBL] [Abstract][Full Text] [Related]
3. Navigating changes in Durham SH; Le P; Cassano AT J Manag Care Spec Pharm; 2020 Dec; 26(12-a Suppl):S3-S23. PubMed ID: 33533699 [No Abstract] [Full Text] [Related]
4. Fecal microbiota transplantation (FMT) for C. difficile infection, just say 'No'. Tan X; Johnson S Anaerobe; 2019 Dec; 60():102092. PubMed ID: 31472233 [TBL] [Abstract][Full Text] [Related]
5. Risk of Clostridium difficile Infection with Systemic Antimicrobial Therapy Following Successful Fecal Microbiota Transplant: Should We Recommend Anti-Clostridium difficile Antibiotic Prophylaxis? Allegretti JR; Kao D; Phelps E; Roach B; Smith J; Ganapini VC; Kassam Z; Xu H; Fischer M Dig Dis Sci; 2019 Jun; 64(6):1668-1671. PubMed ID: 30632052 [TBL] [Abstract][Full Text] [Related]
6. Long-term durability and safety of fecal microbiota transplantation for recurrent or refractory Clostridioides difficile infection with or without antibiotic exposure. Lee CH; Chai J; Hammond K; Jeon SR; Patel Y; Goldeh C; Kim P Eur J Clin Microbiol Infect Dis; 2019 Sep; 38(9):1731-1735. PubMed ID: 31165961 [TBL] [Abstract][Full Text] [Related]
7. Clostridium difficile infection: A brief update on emerging therapies. Goldberg EJ; Bhalodia S; Jacob S; Patel H; Trinh KV; Varghese B; Yang J; Young SR; Raffa RB Am J Health Syst Pharm; 2015 Jun; 72(12):1007-12. PubMed ID: 26025991 [TBL] [Abstract][Full Text] [Related]
8. Recurrent Song JH; Kim YS Gut Liver; 2019 Jan; 13(1):16-24. PubMed ID: 30400734 [TBL] [Abstract][Full Text] [Related]
9. Update on Treatment of Clostridioides difficile Infection. Cho JM; Pardi DS; Khanna S Mayo Clin Proc; 2020 Apr; 95(4):758-769. PubMed ID: 32247350 [TBL] [Abstract][Full Text] [Related]
10. Nuts and Bolts of Fecal Microbiota Transplantation. Krajicek E; Fischer M; Allegretti JR; Kelly CR Clin Gastroenterol Hepatol; 2019 Jan; 17(2):345-352. PubMed ID: 30268564 [TBL] [Abstract][Full Text] [Related]
18. Durable reduction of Clostridioides difficile infection recurrence and microbiome restoration after treatment with RBX2660: results from an open-label phase 2 clinical trial. Orenstein R; Dubberke ER; Khanna S; Lee CH; Yoho D; Johnson S; Hecht G; DuPont HL; Gerding DN; Blount KF; Mische S; Harvey A BMC Infect Dis; 2022 Mar; 22(1):245. PubMed ID: 35279084 [TBL] [Abstract][Full Text] [Related]
19. A review of fecal microbiota, live-jslm for the prevention of recurrent Clostridioides difficile infection. Hunt A; Drwiega E; Wang Y; Danziger L Am J Health Syst Pharm; 2024 Jul; 81(15):e402-e411. PubMed ID: 38470061 [TBL] [Abstract][Full Text] [Related]
20. Exploring ways to improve CDI outcomes. Galpérine T; Guery B; Med Mal Infect; 2018 Feb; 48(1):10-17. PubMed ID: 29336930 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]